Critical Assessment of G Protein-Biased Agonism at the μ-Opioid Receptor

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Low intrinsic efficacy for G protein activation can explain the improved side effect profiles of new opioid agonists2020 · 380 citations
2. 2Agonist-selective recruitment of engineered protein probes and of GRK2 by opioid receptors in living cells2020 · 52 citations
3. 3APOLLO-1: a randomized placebo and active-controlled phase III study investigating oliceridine (TRV130), a G protein-biased ligand at the µ-opioid receptor, for management of moderate-to-severe acute pain following bunionectomy2019 · 168 citations
4. 4Mitragynine/Corynantheidine Pseudoindoxyls As Opioid Analgesics with Mu Agonism and Delta Antagonism, Which Do Not Recruit β-Arrestin-22016 · 328 citations